2-(5-Chloromethyl-[1,2,4]oxadiazol-3-yl)-pyridine, 95.0%, 2.5g

2-((TERT-BUTOXYCARBONYL)AMINO)-3,3,3-TRIFLUOROPROPANOIC ACID, 95.0%, 250mg

N-[(3-ethyl-1,2,4-oxadiazol-5-yl)methyl]ethanamine, 95.0%, 1g

Tert-butyl (2R,4R)-2-cyano-4-hydroxypyrrolidine-1-carboxylate, 97%, 250mg

2-(1H-Pyrazol-4-yl)-ethanol, 95.0%, 10g

Benzaldehyde, 4,4',4''-phosphinidynetris-, 97%, 1g

Theobromine>98.0%(HPLC)(T)500g

Benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate, 98%, 250mg

Flat flange reaction vial, cylindrical, graduated, with tempering jacket GL connecting piece, DN 60, 100 ml, 90 mm, 1 Piece

1-(Bromomethyl)-3-phenoxybenzene, 97.0%, 1g

Wide mouth bottle, 125 ml, 38 mm, 12 Piece(s)

3-BROMO-2,7-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A]PYRIDINE, 95.0%, 100mg

2-Chloro-5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 10g